GSK Can't Sink Avandia Prescription Coverage RICO Suits
GlaxoSmithKline LLC failed Wednesday to escape a trio of racketeering class actions in Pennsylvania federal court alleging its concealment of heart risks associated with the diabetes drug Avandia conned health benefit...To view the full article, register now.
Already a subscriber? Click here to view full article